2014

IMS Health files for IPO

Monday, January 6, 2014

IMS Health, a global information and technology services company, has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

[Read More]

TauRx expands Alzheimer’s clinical trials in the U.S.

Monday, January 6, 2014

TauRx Therapeutics, a clinical-stage biopharmaceutical company developing a novel treatment for Alzheimer’s disease, has expanded its international clinical trials by adding new research centers across the U.S. The addition of 35 clinical research centers means more patients suffering from mild or moderate Alzheimer’s, and their caregivers, will have an opportunity to see if they qualify for participation in TauRx’s Alzheimer’s clinical trials.

[Read More]

Luoxis enters collaborations on oxidative stress

Monday, January 6, 2014

Ampio Pharmaceuticals has announced that its subsidiary, biotechnology company Luoxis, has entered into research agreements with Western Galilee Medical Center and the University of Thessaly. These two oxidative stress research groups will utilize Luoxis’ proprietary RedoxSYS oxidation-reduction potential (ORP) diagnostic system to study oxidative stress markers across hypertension, hemodialysis, sepsis and physical exertion.

[Read More]

EMIG welcomes Parliamentary inquiry into NICE

Monday, January 6, 2014

The Ethical Medicines Industry Group (EMIG) has welcomed the House of Commons Health Select Committee’s inquiry into the National Institute for Health and Clinical Excellence (NICE). This is an opportunity for the SME specialist biopharmaceutical sector to reflect on the workings of the medicines regulator, in particular its future role in supporting the new commissioning environment and how the value of innovative new medicines will be assessed.

[Read More]

Sanofi to expand access to clinical trial data

Friday, January 3, 2014

Starting this month, Sanofi will expand access to information and data from clinical trials sponsored by companies of the Sanofi group, in support of industry-wide efforts to promote a set of Principles for Responsible Sharing of Clinical Trial Data that the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) jointly released in July 2013 and put into effect Jan. 1.

[Read More]